Douglas A Melton

This inventor holds 40 USPTO granted patents and 39 published patent applications and 5 EPO patents, primarily in Stem Cell Research. Top assignees: Harvard College, Genetics Institute, Inc., The Brigham and Women's Hospital, Inc.. Active years: 1997-2024.

USPTO Granted Patents = 40 (Patent Applications = 39)

% Patents Active = 87.5

EPO Patents = 5 (Patent Applications = 20)

Average Co-Inventor Count = 3.3

ph-index = 12

Forward Citations = 487(Granted Patents)

Location History:

Lexington, MA (US) (1997 - 2024)
Cambridge, MA (US) (2023 - 2024)

Company Filing History:

Genetics Institute, Inc.

patents

2 out of 1,424

The Brigham and Women's Hospital, Inc.

patents

4. 1 out of 1,072

Children's Medical Center Corporation

Genetics, Institute Institute, LLC.

patent

7. 1 out of 3,070

The General Hospital Corporation

patents

8. 2 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2024

Loading Chart...

Areas of Expertise:

Stem Cell-Derived β Cells

Diabetes Treatment

Cardiomyocytes

Endocrine Cell Generation

Tendon-Inducing Methods

Neuronal Cell Maintenance

GDF11 Treatment

PDX1+ Pancreatic Cells

Signal Transduction Proteins

Hepatosteatosis Reduction

Inhibitors of GSK-3

Serum-Free Differentiation

40 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12123023 - Methods for generating stem cell-derived β cells and methods of use thereof (2024-10-22),

2. 12097239 - Methods and compositions for treating diabetes, and methods for enriching MRNA coding for secreted proteins (2024-09-24),

3. 12054745 - SC-beta cells and compositions and methods for generating the same (2024-08-06),

4. 12049646 - SC-beta cells and compositions and methods for generating the same (2024-07-30),

5. 11890321 - Method of treating or inhibiting glucose intolerance (2024-02-06),

6. 11850266 - Cardiomyocytes and compositions and methods for producing the same (2023-12-26),

7. 11827905 - SC-beta cells and compositions and methods for generating the same (2023-11-28),

8. 11162078 - SC-beta cells and compositions and methods for generating the same (2021-11-02),

9. 11155787 - Methods for generating stem cell-derived beta cells and methods of use thereof (2021-10-26),

10. 11136554 - Methods of reprogramming cells (2021-10-05),

11. 11104883 - SC-beta cells and compositions and methods for generating the same (2021-08-31),

12. 11085027 - Serum-free in vitro directed differentiation protocol for generating stem cell-derived beta cells and uses thereof (2021-08-10),

13. 11085026 - Serum-free in vitro directed differentiation protocol for generating stem cell-derived beta cells and uses thereof (2021-08-10),

14. 11085025 - Serum-free in vitro directed differentiation protocol for generating stem cell-derived beta cells and uses thereof (2021-08-10),

15. 11078463 - SC-beta cells and compositions and methods for generating the same (2021-08-03),

Title: Douglas A. Melton - Pioneering Inventor from Lexington, MA

Introduction: Douglas A. Melton is a renowned inventor based in Lexington, MA, known for his groundbreaking contributions to the field of science and technology.

Latest Patents: Douglas A. Melton holds several patents in the areas of biotechnology and medical research, focusing on innovative solutions for various health challenges.

Career Highlights: With a distinguished career spanning decades, Douglas A. Melton has made significant strides in stem cell research, diabetes treatment, and regenerative medicine, earning him global recognition.

Collaborations: Throughout his career, Douglas A. Melton has collaborated with leading scientists, research institutions, and pharmaceutical companies to further advance the frontiers of scientific discovery and innovation.

Conclusion: Douglas A. Melton's relentless pursuit of scientific excellence and his commitment to improving human health through innovative inventions continue to inspire the next generation of inventors and researchers worldwide.